DOI . ORG {}

Analyzed Page
Matching Content Categories
CMS
Monthly Traffic Estimate
How Does Doi.org Make Money
Keywords
Topics
Schema
External Links
Analytics And Tracking
Libraries
Hosting Providers
CDN Services

We began analyzing https://link.springer.com/article/10.1007/s00401-003-0809-8, but it redirected us to https://link.springer.com/article/10.1007/s00401-003-0809-8. The analysis below is for the second page.

Title[redir]:
Expression of oligodendrocyte lineage genes in oligodendroglial and astrocytic gliomas | Acta Neuropathologica
Description:
The oligodendrocyte lineage genes OLIG1 and OLIG2 have been reported as potential diagnostic markers for oligodendrogliomas [Lu et al. (2001) Proc Natl Acad Sci USA 98:10851–10856; Marie et al. (2001) Lancet 358:298–300]. We investigated the mRNA expression of OLIG1 and OLIG2, as well as four other genes involved in oligodendrocyte development (E2A, HEB, NKX2.2, and PDGFRA) in a panel of 70 gliomas, including 9 oligodendrogliomas, 11 anaplastic oligodendrogliomas, 5 oligoastrocytomas, 10 anaplastic oligoastrocytomas, 10 diffuse astrocytomas, 10 anaplastic astrocytomas, and 15 glioblastomas. Most tumors demonstrated higher transcript levels of these genes as compared to non-neoplastic adult brain tissue. Four glioblastomas showed markedly increased PDGFRA mRNA expression due to PDGFRA gene amplification. Statistical analyses revealed no significant expression differences between oligodendroglial and astrocytic tumors. In oligodendroglial tumors, expression of the six genes was not significantly correlated to loss of heterozygosity on chromosome arms 1p and 19q. Thus, expression of the investigated oligodendrocyte lineage genes is up-regulated relative to non-neoplastic brain tissue in the majority of oligodendroglial and astrocytic tumors, suggesting that glioma cells are arrested in or recapitulate molecular phenotypes corresponding to early stages of glial development. However, the determination of mRNA expression of these genes by means of reverse transcription-PCR does not appear to be diagnostically useful as a marker for oligodendrogliomas.

Matching Content Categories {📚}

Education
Science
Photography

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We're unsure how the site profits.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Doi.org could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

google, scholar, oligodendrocyte, pubmed, expression, olig, article, cas, genes, oligodendroglial, factor, lineage, tumors, development, human, gliomas, reifenberger, oligodendrogliomas, glial, growth, privacy, cookies, content, astrocytic, brain, cells, molecular, access, plateletderived, neuropathol, publish, search, nkx, pdgfra, anaplastic, tissue, gene, oligodendroglioma, cancer, differentiation, exp, neurol, data, information, log, journal, research, acta, riemenschneider, koy,

Topics {✒️}

platelet-derived growth factor month download article/chapter spinal oligodendrocyte progenitors human glial tumors heinrich-heine-university oligodendrocyte lineage genes neoplastic brain tissue cold spring harbor oligodendrocyte progenitor cells privacy choices/manage cookies glial development full article pdf sonic hedgehog koy & guido reifenberger reverse transcription-pcr oligodendroglial tumour cells significant expression differences european economic area statistical analyses revealed idh-mutant astrocytoma spatially mixed astrocytoma related subjects diagnostic neuro-oncology human glioma tissue conditions privacy policy chromosome arms 1p chromosome arm 1p potential diagnostic markers 1p/19q codeletion 1p/19q status recapitulate molecular phenotypes accepting optional cookies human malignant gliomas pdgfra gene amplification receptor expression oligodendrocyte development check access instant access oligodendrocyte differentiation regulated relative acta neuropathol 107 journal finder publish guido reifenberger mrna expression article log glioma cells oligodendroglial lineage astrocytic tumors cancer res 52 cancer res 56

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Expression of oligodendrocyte lineage genes in oligodendroglial and astrocytic gliomas
         description:The oligodendrocyte lineage genes OLIG1 and OLIG2 have been reported as potential diagnostic markers for oligodendrogliomas [Lu et al. (2001) Proc Natl Acad Sci USA 98:10851–10856; Marie et al. (2001) Lancet 358:298–300]. We investigated the mRNA expression of OLIG1 and OLIG2, as well as four other genes involved in oligodendrocyte development (E2A, HEB, NKX2.2, and PDGFRA) in a panel of 70 gliomas, including 9 oligodendrogliomas, 11 anaplastic oligodendrogliomas, 5 oligoastrocytomas, 10 anaplastic oligoastrocytomas, 10 diffuse astrocytomas, 10 anaplastic astrocytomas, and 15 glioblastomas. Most tumors demonstrated higher transcript levels of these genes as compared to non-neoplastic adult brain tissue. Four glioblastomas showed markedly increased PDGFRA mRNA expression due to PDGFRA gene amplification. Statistical analyses revealed no significant expression differences between oligodendroglial and astrocytic tumors. In oligodendroglial tumors, expression of the six genes was not significantly correlated to loss of heterozygosity on chromosome arms 1p and 19q. Thus, expression of the investigated oligodendrocyte lineage genes is up-regulated relative to non-neoplastic brain tissue in the majority of oligodendroglial and astrocytic tumors, suggesting that glioma cells are arrested in or recapitulate molecular phenotypes corresponding to early stages of glial development. However, the determination of mRNA expression of these genes by means of reverse transcription-PCR does not appear to be diagnostically useful as a marker for oligodendrogliomas.
         datePublished:2004-01-17T00:00:00Z
         dateModified:2004-01-17T00:00:00Z
         pageStart:277
         pageEnd:282
         sameAs:https://doi.org/10.1007/s00401-003-0809-8
         keywords:
            Oligodendroglioma
            Oligodendrocyte lineage genes
            Olig1
            Olig2
            Pathology
            Neurosciences
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-003-0809-8/MediaObjects/s00401-003-0809-8fmb1.tif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-003-0809-8/MediaObjects/s00401-003-0809-8fmb2.tif
         isPartOf:
            name:Acta Neuropathologica
            issn:
               1432-0533
               0001-6322
            volumeNumber:107
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Markus J. Riemenschneider
               affiliation:
                     name:Heinrich-Heine-University
                     address:
                        name:Department of Neuropathology, Heinrich-Heine-University, Düsseldorf, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Timmo H. Koy
               affiliation:
                     name:Heinrich-Heine-University
                     address:
                        name:Department of Neuropathology, Heinrich-Heine-University, Düsseldorf, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Guido Reifenberger
               affiliation:
                     name:Heinrich-Heine-University
                     address:
                        name:Department of Neuropathology, Heinrich-Heine-University, Düsseldorf, Germany
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Expression of oligodendrocyte lineage genes in oligodendroglial and astrocytic gliomas
      description:The oligodendrocyte lineage genes OLIG1 and OLIG2 have been reported as potential diagnostic markers for oligodendrogliomas [Lu et al. (2001) Proc Natl Acad Sci USA 98:10851–10856; Marie et al. (2001) Lancet 358:298–300]. We investigated the mRNA expression of OLIG1 and OLIG2, as well as four other genes involved in oligodendrocyte development (E2A, HEB, NKX2.2, and PDGFRA) in a panel of 70 gliomas, including 9 oligodendrogliomas, 11 anaplastic oligodendrogliomas, 5 oligoastrocytomas, 10 anaplastic oligoastrocytomas, 10 diffuse astrocytomas, 10 anaplastic astrocytomas, and 15 glioblastomas. Most tumors demonstrated higher transcript levels of these genes as compared to non-neoplastic adult brain tissue. Four glioblastomas showed markedly increased PDGFRA mRNA expression due to PDGFRA gene amplification. Statistical analyses revealed no significant expression differences between oligodendroglial and astrocytic tumors. In oligodendroglial tumors, expression of the six genes was not significantly correlated to loss of heterozygosity on chromosome arms 1p and 19q. Thus, expression of the investigated oligodendrocyte lineage genes is up-regulated relative to non-neoplastic brain tissue in the majority of oligodendroglial and astrocytic tumors, suggesting that glioma cells are arrested in or recapitulate molecular phenotypes corresponding to early stages of glial development. However, the determination of mRNA expression of these genes by means of reverse transcription-PCR does not appear to be diagnostically useful as a marker for oligodendrogliomas.
      datePublished:2004-01-17T00:00:00Z
      dateModified:2004-01-17T00:00:00Z
      pageStart:277
      pageEnd:282
      sameAs:https://doi.org/10.1007/s00401-003-0809-8
      keywords:
         Oligodendroglioma
         Oligodendrocyte lineage genes
         Olig1
         Olig2
         Pathology
         Neurosciences
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-003-0809-8/MediaObjects/s00401-003-0809-8fmb1.tif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-003-0809-8/MediaObjects/s00401-003-0809-8fmb2.tif
      isPartOf:
         name:Acta Neuropathologica
         issn:
            1432-0533
            0001-6322
         volumeNumber:107
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Markus J. Riemenschneider
            affiliation:
                  name:Heinrich-Heine-University
                  address:
                     name:Department of Neuropathology, Heinrich-Heine-University, Düsseldorf, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Timmo H. Koy
            affiliation:
                  name:Heinrich-Heine-University
                  address:
                     name:Department of Neuropathology, Heinrich-Heine-University, Düsseldorf, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Guido Reifenberger
            affiliation:
                  name:Heinrich-Heine-University
                  address:
                     name:Department of Neuropathology, Heinrich-Heine-University, Düsseldorf, Germany
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Acta Neuropathologica
      issn:
         1432-0533
         0001-6322
      volumeNumber:107
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Heinrich-Heine-University
      address:
         name:Department of Neuropathology, Heinrich-Heine-University, Düsseldorf, Germany
         type:PostalAddress
      name:Heinrich-Heine-University
      address:
         name:Department of Neuropathology, Heinrich-Heine-University, Düsseldorf, Germany
         type:PostalAddress
      name:Heinrich-Heine-University
      address:
         name:Department of Neuropathology, Heinrich-Heine-University, Düsseldorf, Germany
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Markus J. Riemenschneider
      affiliation:
            name:Heinrich-Heine-University
            address:
               name:Department of Neuropathology, Heinrich-Heine-University, Düsseldorf, Germany
               type:PostalAddress
            type:Organization
      name:Timmo H. Koy
      affiliation:
            name:Heinrich-Heine-University
            address:
               name:Department of Neuropathology, Heinrich-Heine-University, Düsseldorf, Germany
               type:PostalAddress
            type:Organization
      name:Guido Reifenberger
      affiliation:
            name:Heinrich-Heine-University
            address:
               name:Department of Neuropathology, Heinrich-Heine-University, Düsseldorf, Germany
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Neuropathology, Heinrich-Heine-University, Düsseldorf, Germany
      name:Department of Neuropathology, Heinrich-Heine-University, Düsseldorf, Germany
      name:Department of Neuropathology, Heinrich-Heine-University, Düsseldorf, Germany
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(120)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

Emails and Hosting {✉️}

Mail Servers:

mx.zoho.eu
mx2.zoho.eu
mx3.zoho.eu

Name Servers:

josh.ns.cloudflare.com
zita.ns.cloudflare.com

CDN Services {📦}

Crossref

4.71s.